ACO-SWITCH Trial to Track Serum Transthyretin After Tafamidis-to-Acoramidis Switch
A newly published protocol details ACO-SWITCH, a phase 4 single-arm study that will measure serum transthyretin changes in 50 adults with ATTR-CM switching from tafamidis to acoramidis. Subject of Research: A phase 4 study protocol evaluating serum transthyretin changes in patients with ATTR-CM…